As of 2026-05-22, the EV/EBITDA ratio of Evoke Pharma Inc (EVOK) is -2.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EVOK's latest enterprise value is 12.34 mil USD. EVOK's TTM EBITDA according to its financial statements is -5.19 mil USD. Dividing these 2 quantities gives us the above EVOK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 13.2x | 10.3x |
| Forward P/E multiples | 12.7x - 15.4x | 14.1x |
| Fair Price | (34.51) - (36.08) | (33.00) |
| Upside | -413.8% - -428.0% | -400.0% |
| Date | EV/EBITDA |